Brief: IPCA Labs Says FDA Removed Exemption From Import Alert For Hydroxychloroquine Sulphate
02/07/2020 05:04
July 2 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* US FDA REMOVED EXEMPTION GIVEN TO CO FROM IMPORT ALERT FOR
API,
FORMULATION OF HYDROXYCHLOROQUINE SULPHATE
Source text for Eikon: ID:nBSE62NgwF
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees